| 24103895
|
Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children. |
Vaccine |
2013 |
Englund JA;Karron RA;Cunningham CK;Larussa P;Melvin A;Yogev R;Handelsman E;Siberry GK;Thumar B;Schappell E;Bull CV;Chu HY;Schaap-Nutt A;Buchholz U;Collins PL;Schmidt AC |
View
More |
| 25483333
|
Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model. |
Gut Microbes |
2014 |
Kandasamy S;Chattha KS;Vlasova AN;Rajashekara G;Saif LJ |
View
More |
| 31075351
|
Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease. |
Antiviral Res |
2019 |
Kotomina T;Isakova-Sivak I;Matyushenko V;Kim KH;Lee Y;Jung YJ;Kang SM;Rudenko L |
View
More |
| 31211158
|
Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Overattenuated. |
Open Forum Infect Dis |
2019 |
Cunningham CK;Karron R;Muresan P;McFarland EJ;Perlowski C;Libous J;Thumar B;Gnanashanmugam D;Moye J Jr;Schappell E;Barr E;Rexroad V;Aziz M;Deville J;Rutstein R;Yang L;Luongo C;Collins P;Buchholz U |
View
More |
| 31758177
|
Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children. |
J Infect Dis |
2020 |
McFarland EJ;Karron RA;Muresan P;Cunningham CK;Libous J;Perlowski C;Thumar B;Gnanashanmugam D;Moye J;Schappell E;Barr E;Rexroad V;Fearn L;Spector SA;Aziz M;Cielo M;Beneri C;Wiznia A;Luongo C;Collins P;Buchholz UJ |
View
More |
| 32344618
|
Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T-cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T-Cell Responses and Protect Mice against Both Infections. |
Vaccines (Basel) |
2020 |
Isakova-Sivak I;Matyushenko V;Stepanova E;Matushkina A;Kotomina T;Mezhenskaya D;Prokopenko P;Kudryavtsev I;Kopeykin P;Sivak K;Rudenko L |
View
More |
| 32729747
|
Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned. |
Expert Rev Vaccines |
2020 |
Pereira P;Vetter V;Standaert B;Benninghoff B |
View
More |
| 35062744
|
Escherichia coli Nissle 1917 Enhances Efficacy of Oral Attenuated Human Rotavirus Vaccine in a Gnotobiotic Piglet Model. |
Vaccines (Basel) |
2022 |
Michael H;Miyazaki A;Langel SN;Amimo JO;Kick MK;Chepngeno J;Paim FC;Fischer DD;Rajashekara G;Saif LJ;Vlasova AN |
View
More |
| 35992634
|
Development of a Biosensor Based on Angiotensin-Converting Enzyme II for Severe Acute Respiratory Syndrome Coronavirus 2 Detection in Human Saliva. |
Front Sens (Lausanne) |
2022 |
Moreira G;Casso-Hartmann L;Datta SPA;Dean D;McLamore E;Vanegas D |
View
More |
| 36189239
|
Engineering the common cold to be a live-attenuated SARS-CoV-2 vaccine. |
Front Immunol |
2022 |
Kasman LM |
View
More |
